BIOTRONIK Announces 12-Month Results from 4EVER Study

News   Nov 19, 2012

 
BIOTRONIK Announces 12-Month Results from 4EVER Study
 
 
 

RELATED ARTICLES

Investigational Drug for Melanoma Shows Promise in Early-Stage Study

News

An investigational compound designed to block a hyperactive cell growth signal in advanced melanoma and other cancers has shown some promise in an early-stage clinical trial researchers have reported.

READ MORE

Scientists Report The Development of a Potent New Medicine to Fight Addiction

News

Scientists report the development of a potent new medicine to fight addiction.

READ MORE

Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain Therapeutics

News

The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE